Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance

被引：14
作者：
van Deun, Armand [1 ,2 ]
Chiang, Chen-Yuan [1 ,3 ,4 ]
机构：
[1] Int Union TB & Lung Dis, Paris, France
[2] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium
[3] Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan
[4] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, 111 Hsin Long Rd,Sect 3, Taipei, Taiwan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 49卷 / 06期
关键词：
DRUG-RESISTANCE;
D O I：
10.1183/13993003.00223-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 10 条
[1]   Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients [J].
Aung, K. J. M. ;
Van Deun, A. ;
Declercq, E. ;
Sarker, M. R. ;
Das, P. K. ;
Hossain, M. A. ;
Rieder, H. L. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (10) :1180-1187
[2]   Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis [J].
Bernard, Christine ;
Veziris, Nicolas ;
Brossier, Florence ;
Sougakoff, Wladimir ;
Jarlier, Vincent ;
Robert, Jerome ;
Aubry, Alexandra .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (03) :1524-1529
[3]   Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis [J].
Chiang, C-Y. ;
Van Deun, A. ;
Riederi, H. L. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (09) :1143-1147
[4]   Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling [J].
Gumbo, T ;
Louie, A ;
Deziel, MR ;
Parsons, LM ;
Salfinger, M ;
Drusano, GL .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1642-1651
[5]   Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country [J].
Javaid, Arshad ;
Ahmad, Nafees ;
Khan, Amer Hayat ;
Shaheen, Zubair .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (01)
[6]   Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe [J].
Lange, Christoph ;
Duarte, Raquel ;
Frechet-Jachym, Mathilde ;
Guenther, Gunar ;
Guglielmetti, Lorenzo ;
Olaru, Ioana D. ;
Oliveira, Olena ;
Rumetshofer, Rudolf ;
Veziris, Nicolas ;
van Leth, Frank .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (08) :1029-1031
[7]   High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses [J].
Piubello, A. ;
Harouna, S. Hassane ;
Souleymane, M. B. ;
Boukary, I. ;
Morou, S. ;
Daouda, M. ;
Hanki, Y. ;
Van Deun, A. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (10) :1188-1194
[8]   Specific gyrA gene mutations predict poor treatment outcome in MDR-TB [J].
Rigouts, L. ;
Coeck, N. ;
Gumusboga, M. ;
de Rijk, W. B. ;
Aung, K. J. M. ;
Hossain, M. A. ;
Fissette, K. ;
Rieder, H. L. ;
Meehan, C. J. ;
de Jong, B. C. ;
Van Deun, A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (02) :314-323
[9]   Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard [J].
Van Deun, Armand ;
Aung, Kya J. M. ;
Bola, Valentin ;
Lebeke, Rossin ;
Hossain, Mohamed Anwar ;
de Rijk, Willem Bram ;
Rigouts, Leen ;
Gumusboga, Aysel ;
Torrea, Gabriela ;
de Jong, Bouke C. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (08) :2633-2640
[10]   Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations [J].
Varaine, Francis ;
Guglielmetti, Lorenzo ;
Huerga, Helena ;
Bonnet, Maryline ;
Kiria, Nana ;
Sitienei, Joseph K. ;
Rich, Michael ;
Mitnick, Carole D. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (08) :1028-1029
1